(Q33955184)

30 July 2017

1 reference

title

Immunosuppression in older renal transplant patients (English)

1 reference

30 July 2017

1 reference

J M Morales

1

1 reference

30 July 2017

J M Campistol

series ordinal

2

1 reference

30 July 2017

A Andrés

series ordinal

3

1 reference

30 July 2017

J C Herrero

series ordinal

4

1 reference

30 July 2017

publication date

1 April 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

16

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

279-287

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200016040-00004

30 July 2017

exact match

0 references

cites work

Cadaveric renal transplantation with cyclosporine in patients more than 60 years of age

1 reference

12 December 2020

Kidney transplantation in patients between 65 and 75 years of age.

1 reference

12 December 2020

Renal transplantation in older patients with double therapy with optional change to cyclosporine monotherapy: long-term results

1 reference

12 December 2020

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

1 reference

12 December 2020

One-hundred and five cadaveric kidney transplants with cyclosporine in recipients more than 60 years of age

1 reference

12 December 2020

Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group

1 reference

12 December 2020

The therapeutic use of azathioprine in renal transplantation

1 reference

12 December 2020

Renal transplantation in patients over 55 years old.

1 reference

12 December 2020

Use of antithymocyte globulin for reversal of acute allograft rejection

1 reference

12 December 2020

A prospective randomized trial of FK506-based immunosuppression after renal transplantation

1 reference

12 December 2020

Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine

1 reference

12 December 2020

A randomized trial of deflazacort versus 6-methylprednisolone in renal transplantation--immunosuppressive activity and side effects

1 reference

12 December 2020

A novel approach to the treatment of chronic allograft nephropathy

1 reference

12 December 2020

Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group

1 reference

12 December 2020

Adverse effects associated with the use of FK 506

1 reference

12 December 2020

The use of bilateral adult renal allografts - a method to optimize function from donor kidneys with suboptimal nephron mass

1 reference

12 December 2020

Antilymphocyte induction therapy in cadaver renal transplantation: a retrospective, multicenter United Network for Organ Sharing Study

1 reference

12 December 2020

Comparison of Minnesota antilymphoblast globulin and Upjohn antithymocyte globulin for induction immunosuppression of human renal allografts

1 reference

12 December 2020

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

1 reference

12 December 2020

Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.

1 reference

12 December 2020

Kidney transplantation in patients older than 70 years of age

1 reference

12 December 2020

Current experience with renal transplantation in older patients

1 reference

12 December 2020

A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group

1 reference

12 December 2020

Mycophenolate-update after it has come of age

1 reference

12 December 2020

Renal transplantation in older people

1 reference

12 December 2020

Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients

1 reference

12 December 2020

Recipient age--an important factor for the outcome of cadaver renal transplantation in patients treated with cyclosporine

1 reference

12 December 2020

THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE

1 reference

12 December 2020

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

1 reference

12 December 2020

Renal transplantation in patients more than 65 years old

1 reference

12 December 2020

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group

1 reference

12 December 2020

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression

1 reference

12 December 2020

1 reference

12 December 2020

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

12 December 2020

Cyclosporine monotherapy versus OKT3 and cyclosporine versus prednisone and cyclosporine as induction therapy in older renal transplant patients: a multicenter randomized study. Spanish Monotherapy Study Group

1 reference

12 December 2020

Renal transplantation for patients 60 years of older. A single-institution experience.

1 reference

12 December 2020

Renal transplantation in patients 65 years old or older

1 reference

12 December 2020

FK 506 for liver, kidney, and pancreas transplantation

1 reference

12 December 2020

Cadaveric renal transplantation in patients of 60 years and above

1 reference

12 December 2020

Double versus single renal allografts from aged donors

1 reference

12 December 2020

The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60

1 reference

12 December 2020

Kidney transplantation in patients aged sixty years and older

1 reference

12 December 2020

Survival on renal replacement therapy: data from the EDTA Registry.

1 reference

12 December 2020

Renal replacement therapy in patients aged over 60 years

1 reference

12 December 2020

Cadaver kidney transplantation in patients more than 65 years old

1 reference

12 December 2020

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

1 reference

12 December 2020

Monoclonal antibodies in organ transplantation

1 reference

12 December 2020

Renal transplantation in patients over sixty years of age

1 reference

12 December 2020

Optimal use for older donor kidneys: older recipients.

1 reference

12 December 2020

Cadaveric Renal Transplantation in Elderly Recipients: Is It Worthwhile?

1 reference

12 December 2020

10.2165/00002512-200016040-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1000603016

0 references

1 reference